Circulating MKRN3 levels decline prior to pubertal onset and through puberty: a longitudinal study of healthy girls
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Circulating MKRN3 levels decline prior to pubertal onset and through puberty : a longitudinal study of healthy girls. / Hagen, Casper P; Sørensen, Kaspar; Mieritz, Mikkel G; Johannsen, Trine Holm; Almstrup, Kristian; Juul, Anders.
I: Journal of Clinical Endocrinology and Metabolism, Bind 100, Nr. 5, 2015, s. 1920-6.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Circulating MKRN3 levels decline prior to pubertal onset and through puberty
T2 - a longitudinal study of healthy girls
AU - Hagen, Casper P
AU - Sørensen, Kaspar
AU - Mieritz, Mikkel G
AU - Johannsen, Trine Holm
AU - Almstrup, Kristian
AU - Juul, Anders
PY - 2015
Y1 - 2015
N2 - CONTEXT: Puberty is initiated by a complex interaction of suppressing and stimulating factors. Genetic studies of familial central precocious puberty have suggested makorin ring finger protein 3 (MKRN3) as a major inhibitor of GnRH secretion during childhood. Furthermore, genetic variation near MKRN3 (rs12148769) affects age at menarche in healthy girls.OBJECTIVE: The purpose of this study was to evaluate whether serum levels of MKRN3 declined before pubertal onset in healthy girls.DESIGN: This was a population-based longitudinal study of healthy Danish girls and a cohort study of early maturing girls.SETTING: The study was performed in the general community and in a tertiary referral center for pediatric endocrinology.PATIENTS OR OTHER PARTICIPANTS: Healthy girls (n = 38) aged 9.3 years (range, 5.9-11.3 years) at baseline and followed for 6.0 years (2.7-7.6 years) (2006-2014) with blood sampling every 6 months and early maturing girls (n = 13) with breast development ay <8.3 years of age were included.MAIN OUTCOME MEASURES: Serum levels of MKRN3 were measured in 354 samples (median, 9 per girl; range, 2-14 per girl), and genotyping of variants near MKRN3 (rs12148769 and rs12439354) was performed.RESULTS: MKRN3 concentrations declined preceding pubertal onset; the geometric mean (95% confidence interval) 3 years before pubertal onset vs the last visit before pubertal onset was 304 pg/mL (264-350 pg/mL) vs 257 pg/mL (243-273 pg/mL), corresponding to a reduction of 15% (1-27%) (P = .033). In prepubertal girls, circulating MKRN3 correlated negatively with gonadotropin levels: for FSH, r = -0.262 (P = .015) and for LH, r = -0.226 (P = .037). After adjustment, MKRN3 levels were lower in early maturing girls than in age-matched prepubertal girls: 171 pg/mL (<25-333 pg/mL) vs 262 pg/mL (94-624 pg/mL) (P = .051). Genetic variants near MKRN3 did not correlate with serum levels of MKRN3.CONCLUSIONS: Declining levels of circulating MKRN3 preceded pubertal onset. The negative correlation between MKRN3 and gonadotropins further supports MKRN3 as a major regulator of hypothalamic GnRH secretion during childhood. Undetectable or low MKRN3 levels were observed in a subgroup of patients with early onset of puberty.
AB - CONTEXT: Puberty is initiated by a complex interaction of suppressing and stimulating factors. Genetic studies of familial central precocious puberty have suggested makorin ring finger protein 3 (MKRN3) as a major inhibitor of GnRH secretion during childhood. Furthermore, genetic variation near MKRN3 (rs12148769) affects age at menarche in healthy girls.OBJECTIVE: The purpose of this study was to evaluate whether serum levels of MKRN3 declined before pubertal onset in healthy girls.DESIGN: This was a population-based longitudinal study of healthy Danish girls and a cohort study of early maturing girls.SETTING: The study was performed in the general community and in a tertiary referral center for pediatric endocrinology.PATIENTS OR OTHER PARTICIPANTS: Healthy girls (n = 38) aged 9.3 years (range, 5.9-11.3 years) at baseline and followed for 6.0 years (2.7-7.6 years) (2006-2014) with blood sampling every 6 months and early maturing girls (n = 13) with breast development ay <8.3 years of age were included.MAIN OUTCOME MEASURES: Serum levels of MKRN3 were measured in 354 samples (median, 9 per girl; range, 2-14 per girl), and genotyping of variants near MKRN3 (rs12148769 and rs12439354) was performed.RESULTS: MKRN3 concentrations declined preceding pubertal onset; the geometric mean (95% confidence interval) 3 years before pubertal onset vs the last visit before pubertal onset was 304 pg/mL (264-350 pg/mL) vs 257 pg/mL (243-273 pg/mL), corresponding to a reduction of 15% (1-27%) (P = .033). In prepubertal girls, circulating MKRN3 correlated negatively with gonadotropin levels: for FSH, r = -0.262 (P = .015) and for LH, r = -0.226 (P = .037). After adjustment, MKRN3 levels were lower in early maturing girls than in age-matched prepubertal girls: 171 pg/mL (<25-333 pg/mL) vs 262 pg/mL (94-624 pg/mL) (P = .051). Genetic variants near MKRN3 did not correlate with serum levels of MKRN3.CONCLUSIONS: Declining levels of circulating MKRN3 preceded pubertal onset. The negative correlation between MKRN3 and gonadotropins further supports MKRN3 as a major regulator of hypothalamic GnRH secretion during childhood. Undetectable or low MKRN3 levels were observed in a subgroup of patients with early onset of puberty.
KW - Adolescent
KW - Child
KW - Child, Preschool
KW - Female
KW - Follicle Stimulating Hormone
KW - Genotype
KW - Healthy Volunteers
KW - Humans
KW - Longitudinal Studies
KW - Luteinizing Hormone
KW - Prospective Studies
KW - Puberty
KW - Puberty, Precocious
KW - Ribonucleoproteins
U2 - 10.1210/jc.2014-4462
DO - 10.1210/jc.2014-4462
M3 - Journal article
C2 - 25695892
VL - 100
SP - 1920
EP - 1926
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 5
ER -
ID: 162373403